7.02

2.48% 0.17

Bioventus Inc (BVS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$6.85

Aprire:

$6.89

Volume 24 ore:

172.47K

Relative Volume:

0.46

Capitalizzazione di mercato:

$455.21M

Reddito:

$555.06M

Utile/perdita netta:

$-39.48M

Rapporto P/E:

-11.70

EPS:

-0.6

Flusso di cassa netto:

$29.05M

1 W Prestazione:

+5.41%

1M Prestazione:

+5.41%

6M Prestazione:

-32.76%

1 anno Prestazione:

+19.19%

Intervallo 1D:

$6.86

$7.04

Intervallo di 1 settimana:

$6.52

$7.21

Portata 52W:

$5.73

$14.38

Bioventus Inc Stock (BVS) Company Profile

Nome

Bioventus Inc

Settore

Healthcare (1160)

Industria

Medical Devices (147)

Telefono

(919) 474-6700

Indirizzo

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Dipendente

930

Cinguettio

Prossima data di guadagno

2025-03-11

Ultimi documenti SEC

BVS's Discussions on Twitter

Confronta BVS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BVS Bioventus Inc	7.02	455.21M	555.06M	-39.48M	29.05M	-0.60
ABT Abbott Laboratories	134.44	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	104.32	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	395.28	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	88.39	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.79	44.46B	5.54B	4.18B	623.10M	7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-17	Aggiornamento	JP Morgan	Underweight → Neutral
2023-12-07	Aggiornamento	Canaccord Genuity	Hold → Buy
2023-08-09	Aggiornamento	Craig Hallum	Hold → Buy
2022-11-22	Downgrade	Craig Hallum	Buy → Hold
2022-11-09	Downgrade	Canaccord Genuity	Buy → Hold
2022-11-09	Downgrade	JP Morgan	Overweight → Underweight
2022-03-15	Iniziato	Craig Hallum	Buy
2021-11-15	Ripresa	Morgan Stanley	Overweight
2021-11-10	Ripresa	JP Morgan	Overweight
2021-07-01	Downgrade	Goldman	Buy → Neutral
2021-03-08	Iniziato	Canaccord Genuity	Buy
2021-03-08	Iniziato	Goldman	Buy
2021-03-08	Iniziato	JP Morgan	Overweight
2021-03-08	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Bioventus Inc Borsa (BVS) Ultime notizie

Jun 19, 2025

(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 19, 2025

Jun 14, 2025

Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail

Jun 14, 2025

Jun 06, 2025

(BVS) Proactive Strategies - news.stocktradersdaily.com

Jun 06, 2025

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

Jun 06, 2025

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting - Investing.com

Jun 04, 2025

Bioventus Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025

Jun 02, 2025

Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

Jun 02, 2025

May 30, 2025

Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week

May 30, 2025

Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

May 30, 2025

May 26, 2025

Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World

May 26, 2025

May 19, 2025

Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

May 18, 2025

Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 18, 2025

May 16, 2025

Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus

May 07, 2025

Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st

May 07, 2025

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 07, 2025